10-QPeriod: Q3 FY2019

ENTEGRIS INC Quarterly Report for Q3 Ended Sep 28, 2019

Filed October 24, 2019For Securities:ENTG

Summary

Entegris, Inc. (ENTG) reported its financial results for the nine months ended September 28, 2019, showing a slight increase in net sales to $1,164.1 million, up 1% from the prior year period. This growth was largely driven by strategic acquisitions, which contributed $71.9 million in net sales, partially offsetting a decrease in volume, pricing, and mix, as well as foreign currency headwinds. The company experienced a decrease in gross profit and margin for both the three-month and nine-month periods, attributed to lower factory utilization, an unfavorable sales mix, and incremental costs associated with integrating recently acquired businesses. Despite these pressures, Entegris reported a significant increase in net income for the nine-month period, reaching $197.4 million, a 30% increase compared to the previous year, primarily due to a substantial one-time gain of $122.0 million from the termination of a merger agreement with Versum Materials, Inc. Management is focusing on organizational changes to enhance responsiveness and competitiveness.

Financial Statements
Beta

Key Highlights

  • 1Net sales for the nine months ended September 28, 2019, increased by 1% to $1,164.1 million, driven by acquisitions.
  • 2Net income for the nine months increased significantly to $197.4 million, largely due to a $122.0 million termination fee from Versum.
  • 3Gross profit decreased by 5% for the nine months ended September 28, 2019, to $514.0 million, with gross margin declining to 44.2% from 47.0% year-over-year.
  • 4Operating income for the nine months declined by 30% to $155.2 million, impacted by increased SG&A and amortization expenses.
  • 5Entegris completed three acquisitions in 2019: Digital Specialty Chemicals (March), MPD Chemicals (July), and Hangzhou Anow Microfiltration Co. (September), totaling significant investment and adding to goodwill and intangible assets.
  • 6Cash and cash equivalents decreased from $482.1 million at the end of 2018 to $282.7 million at September 28, 2019, reflecting investments in acquisitions and share repurchases.
  • 7The company recorded restructuring charges of $1.0 million for the third quarter and $8.9 million year-to-date, part of organizational changes to improve efficiency.

Frequently Asked Questions

Sales for the first nine months of 2019 increased by 1% to $1,164.1 million. This growth was primarily driven by the contribution of newly acquired businesses, which added $71.9 million in net sales. However, this was partially offset by decreases related to volume, pricing, and product mix, as well as unfavorable foreign currency exchange rates.

Gross profit for the nine-month period decreased by 5% to $514.0 million, with a corresponding decline in gross margin from 47.0% to 44.2%. This was attributed to lower factory utilization, an unfavorable sales mix, and integration costs from recent acquisitions. While operating income saw a decline, net income surged to $197.4 million, primarily due to a one-time termination fee from a cancelled merger agreement.

Entegris made three significant acquisitions in 2019: Digital Specialty Chemicals, MPD Chemicals, and Hangzhou Anow Microfiltration. These acquisitions contributed to sales growth and increased the company's goodwill and intangible assets on the balance sheet. The integration of these businesses also resulted in additional amortization expenses and contributed to higher selling, general, and administrative (SG&A) costs.

Cash and cash equivalents decreased from $482.1 million at the end of 2018 to $282.7 million by September 28, 2019. This reduction was largely due to significant investments in acquisitions and substantial share repurchases. Long-term debt remained relatively stable at approximately $938 million.